Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats

International Journal of Cardiology

Volumn 115, Issue 1, 2007, Pages 24-28

  Haugen, E ^a,b   Chen, J ^a   Wikstrom J ^b   Gronros J ^b   Gan, L M ^b   Fu, L X M ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BNP; Cytokine; Heart function; Hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOWN REGULATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HEART ARRHYTHMIA; HEART DISEASE; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HYPERTENSION; INFLAMMATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLE; UPREGULATION;

ANIMALS; CARDIOMEGALY; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HYPERTENSION; HYPERTROPHY; INTERLEUKIN-6; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA;

EID: 33845216828     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.01.031     Document Type: Article

References (9)

1. Sasayama S., Matsumori A., and Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res 42 (1999) 557-564
2. Raymond R.J., Dehmer G.J., Theoharides T.C., and Deliargyris E.N. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141 (2001) 435-438
3. Mann D.L., and Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105 (1994) 897-904
4. Setsuta K., Seino Y., Ogawa T., Ohtsuka T., Seimiya K., and Takano T. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. Circ J 68 (2004) 747-750
5. Mitchell G.F., Pfeffer J.M., and Pfeffer M.A. The transition to failure in the spontaneously hypertensive rats. Am J Hypertens 10 (1997) 120-126
6. Gan L., Wikström J., Brandt-Eliasson U., and Wandt B. Amplitude and velocity of mitral annulus motion in rabbits. Echocardiography 21 4 (2004 (May)) 313-317
7. Sanz-Rosa D., Oubina M.P., Cediel E., et al. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am J Physiol Heart Circ Physiol 288 1 (2005 (Jan)) H111-H115
8. Zen K., Irie H., Doue T., et al. Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy. Int Heart J 46 2 (2005) 231-244
9. Nishio R., Shioi T., Sasayama S., and Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol 41 2 (2003 (Jan 15)) 340-345